Sponsor

Biogencell Ltd.

16, Divrei Khayim, 4244916

About the sponsor

Biogencell Ltd. is focused on clinical research in peripheral arterial disease and critical limb ischemia, particularly in patients with advanced limb ischemia who remain symptomatic despite standard pharmacological management and control of cardiovascular risk factors.

Peripheral arterial disease (PAD)
Critical limb ischemia (CLI)
Chronic limb-threatening ischemia (CLTI)

The sponsor’s research interest includes patients with persistent microvascular disease after prior revascularization and those without remaining options for further revascularization treatment.

About Specializations

Biogencell Ltd. runs clinical trials in conditions such as Peripheral arterial occlusive disease, among others.

Peripheral arterial occlusive disease

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Peripheral arterial occlusive disease

Not recruiting

Investigational

Study on BGC101 for Treating Peripheral Arterial Disease with Critical Limb Ischemia in Patients Not Responding to Standard Treatments

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Autologous Blood-Derived Endothelial Progenitor Cells, Haematopoietic Stem/Progenitor Cells, Activated Dendritic Cells And T Helper Cells
Sponsor:Biogencell Ltd.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →